TNF-α blockers are a type of drug employed in the treatment of multiple inflammatory and autoimmune diseases, and are mainly applied in the first-line treatment of rheumatoid arthritis (Hu et al., 2024). This evidence concerns the gene TNF and rheumatoid arthritis.